Religare Enterprises Limited (REL) is no longer the “sick child” of the Indian financial services sector. After years of navigating the wreckage left by its former promoters and a grueling debt resolution process, the company has officially entered its “Phase 2.0.” The narrative has shifted from survival to structural engineering. With the Burman Group (Dabur promoters) now firmly in the driver’s seat with a 30.27% stake, the organization is undergoing a radical DNA transplant.
The headline for FY26 isn’t just the ₹8,494 crore consolidated revenue; it’s the strategic decision to split the empire. The Board has greenlit a demerger that will carve out the lending and broking businesses into a separately listed entity, Religare Finvest (RFL), leaving the crown jewel—Care Health Insurance—within the original REL shell. While the market digests this 1:1 share swap, the financial statements reveal a complex transition where “timing differences” in insurance accounting are clashing with the aggressive revival of the lending books.
1. At a Glance
The financial year 2026 has been a year of “The Great Clean-up.” Religare Enterprises is currently a house undergoing a massive structural renovation while the family is still living in it. If you look at the surface-level numbers, the Net Profit for Q4 FY26 stood at ₹95.65 crore, a decline of 16.5% YoY. To the untrained eye, this looks like a slowdown. To a seasoned analyst, it’s the cost of a reset.
The company is operating in a high-stakes environment where governance is the primary currency. The “red flags” that once haunted this counter—misappropriation of funds, RBI Corrective Action Plans (CAP), and lender lawsuits—are being systematically burned in the furnace of compliance.
- The Insurance Paradox: Care Health Insurance is growing like a weed, with Gross Written Premiums (GWP) hitting ₹11,417 crore for FY26, up 24%. However, due to the new 1/n accounting rule, a large chunk of this profit is being “deferred,” making the reported PBT look far leaner than the actual cash coming in.
- The Lending Resurrection: Religare Finvest (RFL), which was essentially a “zombie NBFC” for years, has reported a PAT of ₹138.8 crore for FY26. It is now debt-free with a CRAR of 261.9%. This is unheard of in the lending space and suggests RFL is sitting on a mountain of cash, waiting for the demerger to start aggressive lending again.
- The Promoter Puzzle: The Burman family has converted warrants and bought shares from the open market, moving from a “hostile” takeover perception to an “official promoter” designation. This provides the company with the one thing it lacked for a decade: Permanent Capital and Long-term Vision.
The curiosity here lies in the Valuation Gap. While the consolidated entity trades at a P/E of 86, the sum-of-the-parts (SOTP) valuation is the real game. How much is a debt-free NBFC with ₹591 crore in cash worth when paired with India’s 2nd largest standalone health insurer? The market is currently trying to price in the demerger, but the “accounting noise” is keeping the volatility high.
2. Introduction
Religare Enterprises Limited (REL) is a diversified financial services engine that has survived a near-death experience. Founded in 1984, the company was once the poster child for the “Singh Brothers” era, which ended in a spectacular fallout involving misappropriation of over ₹2,500 crore.
Today, it is a Listed Core Investment Company (CIC). It doesn’t do business directly; it owns the titans that do. Its portfolio is divided into four distinct silos:
- Health Insurance: Care Health Insurance (63.2% stake).
- Retail Broking: Religare Broking Limited (100% stake).
- SME Lending: Religare Finvest Limited (100% stake).
- Housing Finance: Religare Housing Development Finance (87.5% stake).
The current management, under the shadow of the Burman Group, is aggressively trying to distance the company from its past. This involves not just changing the board, but changing the business model from a “conglomerate mess” to a “specialized play.”
The latest quarterly results for March 2026 show a consolidated total income of ₹2,473.30 crore. While the expenses have ballooned to ₹2,346 crore—partly due to one-time employee provisions tied to the new labor code—the operating engine is clearly revving. The company is now a “Battlefield Stock,” where institutional interest is rising as the legacy litigation clouds clear.
3. Business Model – WTF Do They Even Do?
If you think Religare is just another finance company, you’re missing the forest for the trees. REL is essentially a Venture Capital fund for its own subsidiaries. ### The Care Health Insurance Engine (The Cash Cow)
This is the heart of the company. It accounts for nearly 75% of the total revenue.
